Effects of hyperbaric oxygen on motor function in children with cerebral palsy

Daniel J Lacey1, Adrienne Stolfi, Louis E Pilati

  • 1Department of Neurology, Children's Medical Center of Dayton, Dayton, OH, USA. laceyd@childrensdayton.org

Annals of Neurology
|October 17, 2012
PubMed

Insights

Hyperbaric oxygen (HBO) did not improve gross motor function in children with cerebral palsy. This therapy was no more effective than hyperbaric air (HBA) for improving other functional measures.

Area of Science:

  • Pediatric Neurology
  • Rehabilitative Medicine
  • Oxygen Therapy

Background:

  • Cerebral palsy (CP) is a group of movement disorders affecting muscle tone and posture.
  • Gross motor function is a key developmental milestone impacted by CP.
  • Hyperbaric oxygen (HBO) therapy is being explored for various neurological conditions.

Purpose of the Study:

  • To evaluate the efficacy of hyperbaric oxygen (HBO) therapy in improving gross motor function in children with cerebral palsy (CP).
  • To compare HBO therapy with hyperbaric air (HBA) as a control in children with CP.

Main Methods:

  • A randomized, double-blind, controlled clinical trial involving 49 children (3-8 years) with spastic cerebral palsy.
  • Participants received 40 treatments of either HBO (100% oxygen) or HBA (14% oxygen) over 8 weeks.
  • Primary outcome: Gross Motor Function Measure (GMFM); Secondary outcome: Pediatric Evaluation of Disability Inventory (PEDI).

Main Results:

  • No significant improvement in GMFM scores was observed in either the HBO or HBA group, nor between the groups.
  • Both groups showed statistically significant increases in PEDI scores, with no discernible difference between HBO and HBA.
  • The study was terminated early due to a low probability of detecting a significant difference between groups.

Conclusions:

  • Hyperbaric oxygen (HBO) therapy is not effective for improving gross motor function in young children with cerebral palsy.
  • HBO therapy demonstrated no superior benefit compared to hyperbaric air (HBA) for functional improvements in this pediatric CP population.
  • Current evidence does not support the use of HBO as a therapeutic intervention for young children with CP, excluding those with neonatal hypoxic-ischemic encephalopathy.
Abstract